Latest Articles
- Atrial fibrillation: New drugs, devices, and procedures
An update on controversies in treating atrial fi brillation: new oral anticoagulants vs warfarin, rate control vs rhythm control, the safety of dronedarone, and the efficacy of ablation.
- Synthetic legal intoxicating drugs
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).
- In reply: Geriatric patient-centered medical home
Readers comment on synthetic legal intoxicating drugs (April 2012) and on the geriatric patient-centered medical home (May 2012).
- The stethoscope as metaphor
The humanities—and bedside skills—ought to be a fundamental part of medical education. The alternative is a future full of technicians with tricorders, but sorely lacking in healers.
- Regularizing the approach to the irregularly irregular
We have more choices, more data, and more management algorithms, but still no panacea for atrial fibrillation.
- A farmer with chest pain and lung nodules
The patient, age 50, was treated 25 years ago for brucellosis. But he is also a 30-pack-year smoker. What does he have?
- Kidneys have a lot of nerve
Renal denervation shows promise. But hypertension is a heterogeneous condition, and the patient’s underlying pathophysiology may dictate the response to this physiologically based therapy.
Renal denervation to treat resistant hypertension: Guarded optimismCan a percutaneous catheter-based procedure cure resistant hypertension? The limited data available so far look good.
- Aortic stenosis: Who should undergo surgery, transcatheter valve replacement?
For some patients with aortic stenosis, the choice of management is simple; for others it is less so.